Salman Haque

Today Haque is co-CEO of Medsender, a New York startup that began as a HIPAA-compliant digital fax tool and grew into something stranger and more useful: an AI layer that reads the unstructured mess of medical communication - faxes, emails, phone calls - and turns it into structured action. Referrals processed the same day. Patients scheduled without a human re-typing a phone number. Documents filed into the right chart automatically. The platform now reaches healthcare providers in all 50 states.

Haque shares the wheel with founder Zain Qayyum in a genuine co-CEO arrangement. Qayyum brought the origin story - a pre-med who watched healthcare operations break up close, then drove two and a half hours between health systems to collect paper and CD copies of his mother's records, then switched from medicine to computer science to fix it. Haque brought the second gear. By the company's own telling, the product "evolved quickly" once he came on board.

Memphis, then Cambridge, then the unglamorous middle of healthcare

Haque graduated from Memphis University School in 2014 - the kind of detail that resurfaces when an alum comes back to run a DECA Club Lunch & Learn, which he did, telling students about his path to Medsender and how the startup uses AI to ease healthcare communication. From Memphis he went to Harvard for an A.B. in economics.

What came next reads like a finance resume right up until it doesn't. A summer at MB Venture Partners. A private-equity summer at Brown Brothers Harriman. The expected path was a bank, a fund, a corner of capital that never touches a patient. Instead, in 2019, he took a Tactical Operations Analyst role at Capsule, the digital pharmacy startup - his first real plunge into the plumbing of healthcare, where the work is logistics, edge cases, and the slow grind of making a broken system move faster.

In 2020 he joined Medsender, first driving growth and then stepping into the co-CEO role. The investing background was not decoration. When Medsender closed its $5M Series A led by Ballast Point Ventures in 2025, it was Haque framing the market for the press: enormous demand, an entire ecosystem to expand into, a partner that could help the company accelerate.

The machine nobody wanted to fix

Automating medical paperwork is not the kind of mission that lands on a magazine cover. There is no consumer app, no viral demo, no glamour. There is a clinic in a strip mall where someone spends their afternoon re-keying a fax. Haque's bet is that the dull, repeated, soul-deadening work is exactly where AI earns its keep - and where a real business hides.

That bet is starting to show its math. Medsender went through Y Combinator's W24 batch, debuted on the Inc. 5000 list of fastest-growing private companies at #550 in 2025, and shipped MAIRA, an AI phone agent the company says can reduce call handling by up to 80%. The early fax tool has become a workflow platform with pre-built integrations into dozens of EMR and EHR systems and an API for the rest.

Ask why a Harvard economics grad with a clean shot at Wall Street ended up here, and the honest answer is in the work itself. The interesting problems were never in the spreadsheet. They were in the waiting room, in the fax tray, in the gap between a doctor's note and a patient's next appointment. Haque went to the gap.